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INTRODUCTION I. 
During the last two decades there has been much interest 
and research into the childhood and adult forms of a disease 
characterized by malabsorbtion that investigators generally 
agree should now be called, as initially suggested by Rubin, 
(25,26) celiac sprue. Before the etiologic agent and character¬ 
istic pathological appearance were elucidated in the nineteen 
fifties, the highly varied presentations of malabsorbtion 
gave rise to many different criteria for diagnosis. This 
variety of opinion resulted in, at best, a highly confusing 
nomenclature. Synonyms for adult celiac sprue included; 
idiopathic steatorrhea, non-tropical sprue, idiopathic sprue, 
sprue syndrome, primary malabsorbtion, Gee-Thaysen disease, 
adult celiac disease, and gluten-induced enteropathy. (9) 
The childhood form of the disease was most commonly called 
"celiac disease". 
Then, in 1950, a Dutch pediatrician (11) first suggested 
the use of a gluten-free diet in the childhood form of the 
disease, and in 1952 the gluten-free diet was introduced in 
adult celiac sprue. (21) This therapy has in general proven 
to be quite effective, (7,13,14,15) although at times unpredic¬ 
table. (27) Some investigators (3,25) believe that variability 
in response is due to variation in the strictness of the diet; 
others (27) believe that this is not the case. All believe 
that there are some non-responders, and whether some of these 
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have a specific variation of the disease is being investi¬ 
gated. (16) 
Rubin's definitive study in 1960 (22) confirmed what 
many investigators had long suspected; that the childhood 
and adult forms of celiac disease were expressions of the 
same basic disease process. Rubin showed that after taking 
peroral biopsies of the small intestine, the proximal 
intestinal abnormality in celiac disease and "idiopathic 
sprue" were identical. There is absence of villi of the 
duodenum and proximal jejunum in patients with celiac sprue 
who are eating gluten. (25) Rubin established the peroral 
small bowel biopsy as a necessity in the diagnosis of 
celiac sprue, and today celiac sprue is the most common 
disease diagnosed by small bowel biopsy. (29) Although the 
small bowel biopsy is characteristic of celiac sprue, it is 
not entirely specific. The other diseases with so called 
"flat" biopsies include: Whipple's disease, hypogamma- 
globulinemic sprue, Zollinger-Ellison syndrome, tropical 
sprue, eosinophilic gastroenteritis, kwashiorkor, and primary 
intestinal lymphoma. (25) Although some of these can be 
excluded on clinical grounds, some cannot. However, celiac 
sprue is the only disease with a "flat" biopsy in which 
the biopsy responds to a gluten-free diet. (25,29) At present, 
therefore, the two accepted and necessary criteria for the 
diagnosis of celiac sprue are the characteristic small bowel 
biopsy and the response to a gluten-free diet. 
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Clinical studies of celiac sprue since 1960 (3,7,14,20, 
23,27) have had the benefit of the above specific diagnostic 
criteria, although not all have strictly adhered to them. 
Nevertheless, their patient selection must certainly be 
considered more exact than earlier studies. Despite this, 
the later studies re-emphasize two characteristics of 
celiac sprue that earlier studies elucidated. The first is 
that celiac sprue presents in a wide variety of ways; some 
being quite subtle. The second, mentioned earlier, is that 
the response to a gluten-free diet is often quite variable 
and unpredictable. Indeed, the clinical, biochemical, and 
biopsy responses to the diet in the same patient seemed 
unrelated to one another. (3) This is often puzzling and 
can seemingly make it difficult to gauge the patients 
response to the diet. 
With these thoughts in mind, it was the purpose of this 
study to look at the 32 patients seen at this hospital since 
1960 with the diagnosis of celiac sprue, addressing ourselves 
to clinical observations similar to those mentioned above, 
and to attempt to gauge the response to a gluten-free diet 
in 30 of these patients. As far as was possible, an attempt 
was made to correlate clinical, biochemical, and pathological 
data in these patients, and thereby hopefully to gain some 




II. MATERIALS AND METHODS 
Approximately 75 charts from the Yale-New Haven Hospital 
and West Haven V.A. Hospital were reviewed in the spring and 
summer of 1971. These included all charts indexed since 
1960 under both the specific diagnostic heading of "celiac 
sprue", (and its synonyms previously mentioned) and the 
broad classification of "malabsorbtion". Since this study 
was to be one on adult celiac sprue, it was decided to 
exclude all patients who had a biopsy diagnosing celiac sprue 
before the age of fifteen. Patients were excluded from the 
study who did not have biopsy proven celiac sprue. A positive 
response to a gluten-free diet, but without a pretreatment 
small bowel biopsy was not considered acceptable. Thirty-two 
patients were accepted into the study. Two patients had the 
diagnosis of celiac sprue made without biopsy and were therefore 
excluded. The remainder of the original seventy-five were 
excluded with diagnoses such as pancreatic insufficiency and 
Laenneds cirrhosis. Thirty of the thirty-two patients met 
Rubin's strict criteria (22,23,24) of a characteristic small 
bowel biopsy and a positive response to the gluten-free diet 
at some point during their follow-up. One patient, J.C., had 
a characteristic small bowel biopsy and a classical clinical 
picture but was lost to follow-up after institution of the 
gluten-free diet. Another patient, E.H., has a characteristic 
small bowel biopsy, but has been diagnosed so recently that as 

this paper is being written, she is being placed on the gluten 
free diet. It was decided to include both of these patients 
in the study. 
While reviewing the charts, the clinical and biochemical 
data collected both at the time of the initial admission, 
and at the various follow-up visits, was recorded. The small 
bowel biopsies were also reviewed. In an effort to amass as 
much follow-up data as possible in this group of patients, 
many of the patients who were being followed by various 
members of the department of Gastroenterology at Yale were 
contacted and asked if they would be re-admitted to the 
hospital's research ward for re-study. Seven patients 
consented to re-admission, and six of these to re-biopsy. 
In reviewing the charts, special attention was paid to: 
the age and sex of the patient, the age at onset of sprue 
symptoms, the age at initial diagnosis, the chief complaint, 
the presenting symptoms and presenting physical signs. The 
total length of follow-up and the various clinical symptoms 
and physical signs at each follow-up visit were recorded. 
Biochemical parameters that were looked at both at the 
time of presentation and during follow-up were: fecal fat 
(quantitative), D-xylose, serum carotene, serum iron, serum 
protein, serum calcium and phosphorus, alkaline phosphatase, 




An attempt was made to re-locate all of the small bowel 
biopsies done on the 32 patients. These numbered 75, which 
included the 32 done initially and a variable number of 
follow-up biopsies. All but 15 small bowel biopsies were 
found. Included in these 15 were 8 pre-treatment biopsies. 
The pathologists' reports on all 8 of these were found , 
however, and all 8 were read as "severe changes, compatible 
with the diagnosis of celiac sprue." 
After all the charts had been reviewed and the seven 
patients had been re-evaluated, the clinical and biochemical 
data, as well as the biopsies,was "scored" in the manner 
described below. This was done in an attempt to quantitate 
the data as much as possible. This in turn served to make 
both clearer and more specific the correlation of the three 
parameters. 
In all 32 patients, 4 clinical parameters were scored, 
however, the parameters varied from patient to patient. 
Most patients had one or two symptoms in common at the time 
of admission, for example, diarrhea and weight loss. Other 
symptoms, however, such as nausea or abdominal pain, would 
be a very crucial element in an individual patient's clinical 
presentation, but not appear in enough patients to allow 
accurate comparison. To arrive at the most accurate clinical 
picture it was elected to score the four parameters in each 
patient that were recorded most consistently in follow-up, and 
best represented the clinical expression of their illness. 
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The parameters from which the four were selected were: 
diarrhea, weight loss, weakness (fatigue), cramps and flatus, 
abdominal pain, nausea and vomiting, bleeding and purpura, 
and sore tongue. The first four represent the most commonly 
scored parameters, but the others occasionally became 
significant. Scores of 1 through 4 were assigned the para¬ 
meters as shown in Table I. 
The biochemical scoring is somewhat more accurate, 
because the data is, of course, quantitative to begin with. 
However, here a mean score had to be arrived at in each case 
because not only were the parameters different from patient 
to patient, but the number of parameters consistently 
followed varied widely from as few as 2 to as many as 8. 
The maximum number of parameters followed in each patient 
were scored and a mean score obtained. The biochemical 
parameters and their scores are listed in Table II. 
The small bowel biopsies that could be relocated (see 
above) were looked at in a double blind fashion by two 
separate observers. We adopted, as did Benson,(3) a grading 
system after Rubin (22,23) of mild, moderate, and severe 
changes. We then scored normal as 1, mild as 2, moderate as 
3 and severe as 4. The specific criteria of these 4 classi¬ 
fications and scores are presented in Table III, and in 




A. Clinical Observations 
Twenty-nine patients were diagnosed and followed at 
Yale-New Haven Hospital. Of these 17, or 57%, were women 
and 12, or 43%, men. There were three men diagnosed and 
followed at the West Haven Veterans' Administration Hospital. 
The age at onset of sprue symptoms, determined solely by 
history, the age at first biopsy diagnosis, and the duration 
of symptoms before diagnosis are presented in Table IV. 
The three patients who had the initial onset of symptoms 
before age 20 had a spontaneous remission and then a relapse 
which brought them to medical attention and diagnosis. 
Twenty-two of thirty-two, or 68% of the patients, had the 
onset of their symptoms in the third, fourth and fifth decades. 
Green, in his study in 1960, (15) also found that the bulk 
of his patients had the onset of their symptoms between the 
ages of 20 and 40. Nevertheless, it is clear the symptoms 
of adult celiac disease may first manifest themselves at any 
age, and may be present for years before the patients seek 
medical attention. Sixty-eight per cent of the patients were 
diagnosed after the age of 40 and, in fact, 34% after the age 
of 50. 
The chief complaints at the time of initial presentation 
to the hospital of these 32 patients are presented in Table V. 
Sixty-five per cent had diarrhea as part of a chief complaint. 
Seventy-one per cent of the patients in this study had diarrhea 
8 
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and/or weight loss as part of their chief complaint. Eighty-, 
four per cent of the patients had the more "classical" 
complaints of diarrhea, weight loss, and weakness. The 
total array of symptoms, including the chief complaints, 
provided somewhat different results, and is presented in 
Table VI. 
Ninety-four per cent of the patients had diarrhea as 
a symptom and 71% weight loss. Two patients did not have 
diarrhea. One of them, J.C., had primarily ulcer symptoms 
of nausea and vomiting and abdominal pain, and did, in fact, 
have a duodenal ulcer. The other patient, A.R., had chronic 
low weight and weakness, but a history of diarrhea could not 
be elicited. Thirty-three per cent of the patients had 
weakness, and 33% "cramps and gas". Twenty-nine per cent 
had abdominal pain, 26% faltus without cramps, and 19% had 
anorexia. The variety of other svmptoms point out, as do 
the chief complaints, the number of ways that celiac sprue 
may present itself. 
The physical signs recorded at the time of the initial 
phvsical exam are presented in Table VII. Compared to the 
plentitude of patients with multiple symptoms, there were 
few physical signs. Twenty-two per cent of the patients had 
increased skin pigmentation, noted primarily in the palmar 
creases. In two cases there was a generalized increase in 
skin pigmentation without exposure to the sun. In two cases 
the increase in skin pigmentation, in combination with other 
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symptoms, led to the mistaken clinical diagnosis of Addison’s 
disease, for which the patients were initially worked up. 
Twenty-two per cent of the patients had a rash. In 2 patients 
it was diagnosed as psoriasis, in 1 seborrheic dermatitis, 
and in the remaining 4 no diagnosis was recorded initially. 
One patient, J.S., on a gluten-free diet, was subsequently 
diagnosed as having dermatitis herpetiformis. However, a 
careful review of his chart revealed a diagnosis of dermatitis 
herpetiformis many years before his sprue symptoms developed. 
Cachexia was noted in 22% of the patients. Edema of the 
lower extremities was present in 19%, clubbing of the fingers 
in 16%, and abdominal tenderness to deep palpation in 13% of 
the cases. Stool benzidines were positive in 14% of those 
patients tested. One third of the patients, however, were 
not tested or not recorded. Twenty-eight per cent of the 
patients had a normal physical exam. 
B. Biochemical Results 
The biochemical parameters that were recorded at the 
time of initial presentation to the hospital are presented 
in Table VIII. Of the patients tested in each category, five 
hour urinary D-xylose was abnormal in 93%, serum carotene in 
96%, and fecal fat in 95%. Serum albumin was abnormal in 52%, 
and serum calcium in 46%. The electrolytes were abnormal in 
only one patient, M.C., and in this instance the potassium 
was 2.9. The hematocrit was below normal in 40% of the 
patients, the prothrombin time in 42%, and the serum iron was 
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low in 39%. Flat lactose tolerance tests occurred in 100% 
of those patients tested at the time of initial presentation. 
In three of these twelve patients glucose tolerance tests 
were also administered before treatment. None of the patients 
were diabetic. In two of the three patients the glucose 
tolerance tests were normal, while the lactose tolerance 
tests were flat, and in one both the glucose and lactose 
tolerance tests were flat., 
CSmall Bowel Pathology 
All of the small bowel biopsies, both pre and post¬ 
treatment, were reviewed in a double blind fashion by two 
separate observers. Of the 24 pre-treatment biopsies that 
were re-located, 24, or 100%, had changes of the severe type 
previously described. 
D• Follow-up and Scoring of Data 
The total length of follow-up in these 32 patients 
is shown in Table IX. The actual number of follow-up visits 
or admissions varied from patient to patient. Patients were 
re-biopsied at various times. Nine patients were not re-biopsied. 
The number of patients seen and the number biopsied at the 
various time intervals are shown in Table X. 
The scoring method for clinical parameters has been 
previously described. The clinical scores at the time of 
initial presentation and at the various follow-up periods 
are given in Table XI. 
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Graph #1 represents the clinical scores of the 32 
patients at the time of presentation and aL the various 
follow-up periods. The solid line connects the mean 
clinical scores at presentation and at the various follow¬ 
up periods. 
The biochemical scores at presentation, and at the 
various follow-up periods are shown in Table XII. These 
scores are plotted on Graph #2 and the solid line connects 
the mean biochemical scores at presentation and at the 
various follow-up periods. 
The biopsy scores are similarly shown in Table XIII 
and plotted on Graph #3. The solid line again connects 
the mean biopsy scores at presentation and at the various 
follow-up periods. 
Graph #4 represents the mean values of the three 
parameters grafted together for comparison. 
IV, DISCUSSION 
A, Patient Selection and Data Evaluated 
With one exception that has been previously mentioned, 
the criteria for patient selection in this study has followed 
Rubin's strict guidelines. (22,23,24) Follow-up data was 
extensively sought after, and both data at the time of 
initial presentation and follow-up data, including biopsies, 
were carefully evaluated. The study most similar to ours is 
12 - 

that of Benson, Kowlessar and Sleisenger, (3) in which both 
the mode of presentation, and the response to follow-up, 
were studied. However, of the 32 patients studied by that 
group, only 25 had biopsy-proven ceiial sprue. The remaining 
7 did, however, have a favorable response to a gluten-free 
diet. Mann, Brown and Kern's study in 1970 (20) had a 
biopsy-selected group of 21 patients, however, no follow-up 
biopsies were obtained, as they were primarily interested 
in the initial presentation of adult ceiial sprue. In 1962 
Buchan studied ceiial disease, chosing his patients by 
biopsy and response to diet," this study differs from ours 
in that he chose to include children in his study. Shiner 
studied 17 patients in 1963, (27) all of whom had biopsy 
proven disease and were followed. He was primarily 
interested in their response to a gluten-free diet, and 
not in their manner of presentation initially. Other 
clinical studies (4,7,14,15,28) have reported the various 
ways that adult celiac disease can present and its course 
over time, including the response to gluten withdrawal, 
but did not select all their patients by either biopsy or 
response to diet. 
B. Clinical Observations 
In 1960 Green (15) found that in his 120 patients, 
weight loss was never a chief complaint, even though 73% 
of these same patients had diarrhea as their chief complaint. 
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In Stewart's series of 100 patients,(28) weight loss was 
again not mentioned as a chief complaint and, in fact, only 
33% of his patients complained chiefly of diarrhea. Mann, 
Brown and Kern's study (20) emphasized again that adult 
celiac sprue may very well present in other ways than the 
seemingly obvious symptoms of diarrhea and weight loss. 
Only a total of 38% of their patients sought medical 
attention with chief complaints of diarrhea and weight 
loss. Among Benson's (3) 32 patients, however, 75% had 
chief complaints of diarrhea and/or weight loss. Likewise, 
in our study, diarrhea and weight loss are certainly the 
most common chief complaints, and are found in 70% of the 
patients. All of the studies, Benson's included, emphasize 
that celiac sprue patients may have a wide variety of chief 
complaints, a fact that became obvious in the course of our 
study, and is clearly evident in Table V. All of the chief 
complaints encountered in this study have been previously 
reported, (3,9,15,20,28) however, not always with the same 
incidence. For example, Stewart (28) reported that 33% of 
his patients had the chief complaint of abdominal pain, 
while the incidence in our study of abdominal pain as a 
chief complaint was only 9%, There were also symptoms 
reported by other investigators that were not found among 
our patients. These include "painful swelling of the legs" 
(thrombophlebitis) and tetany. (20) 
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In comparing Table V with Table VI it becomes obvious 
that there is otten quite a difference between the incidence 
of a symptom as a chief complaint and its overall incidence 
as it occurs in the patients. For example, 65% of the 
patients had diarrhea as part of their chief complaint, while 
94% of the patients had it as a symptom, and 71% of the 
patients had weight loss, while only 23% had weight loss as 
part of their chief complaint. This type of discrepancy has 
been reported by others. Stewart (23) found that while only 
33% of his patients had diarrhea and none had weight loss as 
part of their chief complaint, 63% had diarrhea and 43% of 
his patients had, in fact, lost weight. Green (15) found 
similar differences. Seventy-three per cent of his patients 
had the chief complaint of diarrhea, while fully 90% had it 
as a symptom. Only 11% of his patients complained chiefly 
of fatigue or weakness, while 95% of the patients complained 
of weakness upon further questioning. None of his patients 
had the chief complaint of weight loss, and again, 88% had 
lost weight. 
Graph #1 points out an equally important point. Not 
only do patients present with a wide variety of chief 
complaints and symptoms, some quite subtle, but also that 
patients who seek medical help and are diagnosed as having 
celiac sprue present in varying degrees of clinical illness. 
Most are moderately or severely ill at presentation, but a 
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range of abnormal to near-normal is present. Mann (20) 
points out that not only is the diagnosis often obscured 
by unusual and varied presenting symptoms, but also by the 
fact that the symptoms are often quite mi Id and non-specific* 
In addition, others (15) have found, as we did, that the 
onset of symptoms in adult celiac sprue is often slow and 
insidious. 
Nine patients had normal physical examinations at 
presentation. In the remaining patients, findings upon 
physical examination at the time that they presented initially 
were few in number, even in patients with multiple symptoms 
and severe clinical disease. All of the physical signs found 
in this study have been previously reported, (1,3,4,5,7,10, 
15,20,28) however, and when present can strengthen one's 
clinical assessment. An increase in skin pigmentation was 
one of the three most commonly encountered physical signs, 
and was manifested by 22% of the patients in this study. 
Bossak's (4) incidence of increased skin pigmentation was 11.7 
and Benson's group (3) found this increase in pigmentation in 
41% of their 32 patients. Twenty-two per cent of our patients 
were found to have skin lesions of various types previously 
described. Stewart (28) reports an incidence of 13% of 
various skin lesions in his patients, and, specifically, 
dermatitis herpetiformis, found in one of our patients, has 
been carefully studied in relation to celiac sprue. (5,6) 
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Clubbing of the fingers was found in 16% of our patients, 
which is close to the figure of 22% reported by others. (3,4) 
Peripheral edema was found in 36% of Bossak's (4) patients; 
we found the incidence to be 19%. Abdominal bloating was 
reported in only two patients in this study, far from the 75% 
incidence reported by Benson. (3) Other physical signs have 
been reported that were not found in our patients, but their 
incidence is not significant. 
At this point the various complications of celiac sprue 
found in our patients should be mentioned. All of these 
complications have been previously reported. (2,3,4,5,7,9,12 , 
16,17,18,25) These complications, as well as illnesses found 
to exist concurrently with celiac sprue, often obscure the 
diagnosis. Such was the case with E.H., our most recent 
patient to be diagnosed, who like A.V., another of our 
patients, has diabetes mellitus. Celiac sprue is certainly 
not the first cause of diarrhea in a diabetic that one 
considers, nevertheless, she eventually came to small bowel 
biopsy, and the classical changes of celiac sprue were found. 
N.H. presented with low back pain and a history of multiple 
traumatic fractures in childhood. She was found to have 
severe osteomalacia. She had only minimal gastrointestinal 
symptoms. Juergens (13) found that only after careful 
questioning could minimal gastrointestinal symptoms be found 
in his patients with osteomalacia secondary to celiac sprue, 
and he concluded that in patients in whom the cause of osteo- 
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maiacia is obscure, sprue should always be considered. 
Another patient, J.S., in whom the diagnosis of celiac sprue 
was initially obscure, presented with severe gastrointestinal 
hemorrhage secondary to malabsorbtion of vitamin K, and 
hypoprothrombinemia, a well known complication of celiac sprue 
(18) After discharge this same patient also developed the 
lesions of dermatitis herpetiformis, a disease associated 
with celiac sprue that has been well studied, (5,6) The 
precise relationship of the two diseases is not clear, since 
neither responds to the therapy of the other. However, 
Brow, Rubin and their associates (5,6) believe that perhaps 
all patients with dermatitis herpetiformis might have a 
characteristic sprue biopsy, although this has not as yet 
been proven. 
Hypogammaglobulinemia has been reported (3,9,25) as a 
complication of celiac sprue. Low gamma G, gamma A, and 
gamma M have all been found, with gamma M usually returning 
to normal in response to the gluten-free diet. (9) In one 
of our patients, D.H., severe hypogammaglobulinemia, with 
gamma A, G, and M all being involved, has persisted despite 
response of other parameters to the gluten-free diet. For 
this, and many other reasons, lymphoma, another known compli¬ 
cation of celiac sprue, (17) is strongly suspected in this 
patient, and in fact was found in another of our patients, B.L 
B.L. was also found to have another complication of celiac 
sprue, (2) multiple small bowel ulcers. These initially 
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prevented a response to the gluten-free diet, and it is 
occasionally this failure of response, as will be discussed 
subsequently, that leads to a search for, and eventual 
diagnosis of, complications of celiac sprue. 
C. Biochemical Findings at Presentation 
As demonstrated in Table VIII, a significant 
number of patients, though not all, were tested in each 
biochemical parameter. The high percentage of patients 
with abnormal d-xylose tests is as expected, and agrees 
with other reports. (10,20) Benson, however, states in 
his study (3) that a normal d-xylose precludes untreated 
adult celiac sprue. We found this not to be the case. 
Two of our patients had normal five hour urinary d-xylose 
tests and were diagnosed by biopsy as having celiac sprue 
and they responded to a gluten-free diet. Serum carotene 
was abnormal in 96% of our patients, higher than Benson6s(3) 
incidence of 73%, but similar to Mann's (20) incidence of 
93%. Although the incidence of steatorrhea has been reported 
as low as 65%, (20) the incidence in this study was 95% as 
measured by 72 hour fecal fat. Low serum albumin has been 
reported as high as 73% (3) and 84% (20) of patients, so it 
was not at all surprising to find that over half (52%) of 
our patients had a low serum albumin. The incidence of low 
serum calcium has been reported in the range of 65%,(3,4,20) 
our figure was again somewhat lower, 46%. Our incidence of 
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abnormal hematocrit, prothrombin time, and serum iron agrees 
with previous studies. (3,4,12,20) It has also long been 
known that lactose is often maiabsorbed as a result of celiac 
sprue, and Cooke (10) reports that it often takes a long 
time for this defect to correct itself. All of the patients 
tested in this study before treatment had a flat lactose 
tolerance curve, however, only two had the classical symptoms 
of cramps, abdominal bloating, and diarrhea. Two patients 
were not re-tested, 7 patients had a normal curve after 
therapy with the gluten-free diet, and in three patients 
the curve remained flat, despite the fact that other 
parameters had returned to normal. Of these three patients, 
two had had the classical symptoms initially. All three 
were kept on a lactose-free and gluten-free diet. 
Graph #2, which represents the biochemical scores of 
the patients, is analagous to Graph #1. It points out that 
the range of biochemical disease in patients with untreated 
celiac sprue is wide, both at presentation and during 
follow-up. 
D. Biopsy Data at Presentation 
The fact that 100% of the pre-treatment biopsies 
were reviewed in a double blind fashion were scored as class 
4 merely re-states Rubin's definition of the pathological 
picture in this disease, that is, that there is a total 
absence of villi from 100% of patients with adult celiac 
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disease who are eating gluten. (25) Since this has been 
the criteria for diagnosis at Yale-New Haven Hospital and 
the West Haven V.A. Hospital, the nature of the study was 
such that non-flat biopsies would not be located. 
E. Follow-up Data and Response to the Gluten-Free Diet 
Before discussing the specific implications of the 
follow-up data, it must be mentioned that although every 
attempt was made to accurately assess the strictness of 
the gluten-free diet in the 30 patients followed, it was, 
in most cases, impossible. Sadly, in most of the charts 
reviewed not so much as a mention of the diet was to be 
found. Therefore, no significant correlation can be made 
between strictness of diet and level of response, as Benson 
has done. (4) In the patients whom we were able to contact 
and re-admit, careful questioning revealed that approximately 
one-half of the patients either occasionally or frequently 
strayed from the diet, sometimes knowingly and sometimes 
not, and simply put up with the consequences. These were 
usually mild diarrhea or abdominal cramps. If the 
indiscretions were continued, weight loss eventually 
resulted. The other half of the patients strictly adhered 
to the diet, and involuntary lapses were noted and corrected 
by the patients themselves. All of the patients stated 
that the diet was not that inconvenient, but on occasion 
they longed for the foods they used to eat, despite their 
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pre-diagnosis state of ill-health. One might, therefore, 
surmise that the 30 patients followed represent all levels 
of adherence to the diet, the strictness depending upon a 
wide variety of factors. Observations made and conclusions 
drawn about the response to the gluten-free diet will be 
made with the assumption that this heterogeneity is the 
rule in clinical practice, and will be found where the 
constant controls of the hospital metabolic ward are 
absent. 
The various graphs on which are plotted the parameters 
of response to the gluten-free diet make several points. 
The first is the obvious one, shown in Graphs #1 and #2, 
that people on a gluten-free diet improve clinically and 
biochemically. They also make it clear that the "mean 
response" curves will not necessarily be followed in any 
individual case. The wide range of clinical and biochemical 
illness is apparent even after gluten-free diet has been 
instituted, showing a variability in response, with the 
majority of patients significantly improved. This 
variability in response has been observed and reported by 
others. (2,3,7,14,21,23,27,31) Graphs #3 and #4 emphasize 
that although clinically and biochemically patients can 
return to normal, their biopsies do not. (3,23,24,27) 
Assuming that the scoring system is roughly equivalent 
in the three parameters, it becomes obvious that the biopsies 
are in general more severe than one would expect from the 
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clinical and biochemical status of the patient, especially 
after the gluten-gree diet has been instituted. The 
general pattern of response is, however, very similar. But 
the graphs do not give one an accurate idea of the response 
to the diet in individual cases, nor do they allow any 
specific correlations to be made among the clinical, 
biochemical, and pathological parameters. Therefore, 
a more complete and more individualized look at the response 
to the gluten-free diet is seen in Table XIV. 
Table XIV represents the response to the gluten-free 
diet in the 30 patients followed. Shiner, (27) who judged 
response by combining the clinical and biochemical parameters, 
found that 13 of his patients responded and 4 did not. 
Buchan, (7) who judged response in the same was as Shiner, 
found a good response in 32 patients, a moderate response 
in 4, and a poor response in 5. However, this table, and 
the two that follow, point out a difficulty that is 
encountered when speaking of the response to the diet, that 
is, that the clinical, biochemical, and biopsy parameters 
may show a very different pattern of response in the same 
patient. The clinical response is, in a sense, the most 
important, for if the patient is normal by biochemical 
measurements, and has a good biopsy response, but is 
clinically very ill, then that patient must be carefully 
re-evaluated. There were 2 patients in this study who did 
not respond at all clinically. The first, R.J., also had 
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no biochemical or biopsy response. The patient died of 
pneumonia, and at autopsy, in addition to celiac sprue, was 
found to have a large ulcer at the gastro-esophageal 
junction, epidermoid carcinoma of the lung, and two large 
lung abscesses. In the second patient, B.L., multiple 
small bowel ulcers, a known complication of celiac sprue, (2) 
were found at laparotomy. Before this she had had 
essentially no clinical response, although her malabsorbtion 
parameters were never significantly abnormal, and her 
follow-up biopsy showed only mild changes. 
The extent and range of the biochemical and biopsy 
response in the 28 patients who did respond, at least 
moderately well, to the gluten-free died is shown in 
Table XV. Looking at Table XV, one wonders whether any 
prediction could ever be made about a patient's response 
to diet in any given parameter, knowing the results of one, 
or even two, parameters in advance. Table XVI, represents 
a comparison of the three parameters looked at in chis study 
in the 9 patients that were the most thoroughly studied in 
all three parameters simultaneously. The table can be used 
to point out possible correlations between parameters, and 
when, if possible, one might predict from one parameter wnat 
another might be. 
The conclusions that can be drawn from this table are 
consistent in all 30 patients followed. The first is that 
if a patient is clinically severely ill, that is, the 

patient's mean clinical score is 3.0 or greater, that 
patient's biochemical and biopsy picture will be moderate 
or severe, and not mild. There is one exception to this 
rule, #29, B.L., who had small bowel ulcers complicating 
her sprue. Her clinical score was severe due to abdominal 
pain and nausea and vomiting, due most probably to her 
ulcers; while her malabsorbtion parameters and her small 
bowel biopsy showed that her sprue was mild, and thus the 
discrepancy. No other patients who were severely ill 
clinically had mild disease by biochemical measurement or 
by biopsy. 
The second prediction that can be made is that if the 
patient by biochemical measurements is moderately to severely 
ill, that is, a score of 2.5 or greater, that patient's 
biopsy will show moderate or severe, and never mild, changes. 
Among the biopsies that were available we found no exceptions 
to this. 
The converse of the above two statements, however, is 
not true, nor could any other correlations or predictions 
be made. If the patient is severely ill biochemically, he 
might be mild, moderate or severely ill clinically. If the 
patient had a moderate or severe biopsy, that patient might 
be mildly, moderately, or severely ill clinically, biochem¬ 
ically or both. Often we found severe changes on biopsy in 
the face of clinically and biochemically mild disease. 
Whether this is related to the length of intestine involved, 
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as Rubin and others suggest, (3,23,24,26) we were unable to 
determine, although this certainly seems a likely explanation. 
In fact, there are many questions about celiac sprue that 
remain unanswered, a fact that makes the disease all the 
more fascinating. For example, assuming that the disease 
is inherited, or at least the pathological small bowel lesions 
what in fact are the trigger mechanisms which allow the 
disease to become clinically manifest over such a wide range 
of ages? That is, in two people with the same small bowel 
lesion, why should one have symptoms at age 25 and the other 
not until age 60? 
It is known that celiac sprue may become clinically 
evident during the stress of pregnancy and following abdominal 
surgery such as gastrectomy, but the vast majority of trigger 
events are only speculated, and the question of sub-clinical 
disease remains very puzzling. It has also been shown that 
in families that have been studied one member may have 
clinical disease while other family members have the character 
istic biopsy and have never had symptoms! Why one exacerbates 
at any given time and another does not may in some way be 
related to the lack of correlation between biopsies and 
clinical symptoms in patients with clinical disease, that is, 
a severe biopsy associated with mild biochemical and clinical 
illness. 
This study by no means answers any of these questions, 




etiology of this disease is determined many of these questions 




Scores of Eight Clinical Parameters of Celiac Sprue 
Diarrhea; 1 - 2 stools . . . „ 1 
3-5 stools .... 2 
6-10 stools ... 3 
greater than 10.. 4 
Weight Loss: 0-4 pounds .... 1 
5-10 pounds ... 2 
10 - 20 pounds .. 3 
greater than 20.. 4 
Weakness (fatigue), cramps and flatus, abdominal pain 
nausea and vomiting, bleeding and purpura, and sore 
tongue were scored in the following manner; 
mentioned as "not present" ; or "normal" .............. 1 
mentioned as "present", or "abnormal" .............. 2 
patient's chief complaint or specifically 
recorded as "very severe" or "4-f" .................. 4 
Range of Total Scores 4-16 




Scores of Nine Biochemical Parameters of Celiac Spruce 
d-xylose greater than 4.5.1 
(5 hour urine) 
(grams) 2.5 - 4.5 . ..2 
1.5 - 2.4 .3 
less than 1.5 .4 
Fecal fat less than 6 .1 
(24 hour) 
(grams) 6 - 10 .2 
11 - 29 .3 
greater than 29 .4 
Carotene 70 - 200 ..1 
(serum) 
(ug%) 50 - 69 ..2 
25 - 49 .3 
less than 25 .4 
Albumin greater than 3.4 .....1 
(serum) 
(gm%) 3.0 - 3.4 .2 
2.5 - 2.9 ..3 
less than 2.5 ........ 4 
Calcium greater than 9.1 .1 
(serum) 
(mg%) 8.5 - 9.0 .2 
7.5 - 8.4 .3 
less than 7.5 .. . 4 




Hematocrit greater than 39 .1 
(Male) 
(%) 35 - 39 .2 
30 - 34 .3 
less than 30 .4 
Hematocrit greater than 37 ...... 1 
(Female) 
(%) 32 - 37 .2 
28 - 31 .3 
less than 28 .....4 
Iron (serum) 60 - 180 .1 
(Male) 
(ug%) 50 - 59 . 2 
40 - 49 .3 
less than 40 .4 
Iron (serum) 50 - 170 ..1 
(Female) 
(ug%) 40 - 49 .2 
30 - 39 .3 
less than 30 .4 
Maximum mean score ... 4 




Scoring of the Small Bowel Biopsies 
Score= 1: Normal - villi tall, slender, and uniform 
in size and shape, villus/crypt ratio 3/1 
or greater. Epithelial cells have clear 
cytoplasm and are columnar, with nuclei 
placed regularly at the cell base. Brush 
border is uniformly thick. Round cells 
are present in the lamina propria, but are 
not concentrated there. (See Figure I) 
Score= 2: Mild changes - villi are formed, but are 
somewhat broader and shorter than normal. 
The villi and the villus/crypt ratio 
often approach normality. However, epi¬ 
thelial cells, especially at the tips of 
the villi, are still abnormal, often the 
nuclei are not basally located, and the 
cells themselves are not as tall and 
columnar as in the normal biopsy. Round 
cells are present in an increased concen¬ 
tration in the lamina propria. The brush 
border has usually returned to normal, 
except, again, at the very tips of the 





Score= 3: This group encompasses the wide range 
between mild and severe. Villi are 
present, but they are broad and short. 
Epithelial cells are not yet columnar, 
and their nuclei are disoriented, but less 
so than in class 4. The round cell infil¬ 
trate is dense, but again less so than in 
the severe biopsy. The villus/crypt ratio 
is often still less than 1. (See Figure III) 
Score= 4: Complete absence of villi, or, at best, 
very short and very broad. There is 
flattening of the mucosal surface, with 
absence and irregularity of the brush 
border. The epithelial cells themselves 
are columnar, often vacuolated, and have 
nuclei scattered anywhere from the base of 
the cell to the tip. The villus/crypt ratio 
is less than 1 and often is 1/3 or less. 
There is an obvious increase in mitotic 
figures in the crypts. There is a dense 
infiltrate in the lamina propria of chronic 




Age Factors and Duration of Symptoms 
before Diagnosis in Celiac Sprue 
Number of patients Number of patients 
Age Groups at onset of symptoms at time of diagnosis 
Childhood 1 - 
15-19 yrs. 2 - 
20-29 yrs. 9 5 
30-39 yrs. 6 5 
40-49 yrs. 7 11 
50-59 yrs. 4 6 
60-69 yrs. 3 5 
Duration of Symptoms 



















Chief Complaint at Time of 
Initial Presentation 
Diarrhea alone - 10 patients 
Diarrhea & weight loss - 6 patients 
Diarrhea, nausea and vomiting - 2 patie 
Diarrhea & fatigue - 1 patient 
Diarrhea & flatus - 1 patient 
Diarrhea & abdominal pain - 1 patient 
Weight loss alone - 1 patient 
Weight loss and increased pigmentation 
Weakness - 1 patient 
Fatigue - 1 patient 
Sore tongue - 1 patient 
Abdominal pain, nausea and vomiting - 2 
Swelling of legs - 1 patient 
Difficulty walking - 1 patient 
Low back pain - 1 patient 
Total - 32 patients 
nts DIARRHEA 
21 patients 





Symptoms at Time of Initial Presentation 
of 32 Patients with Adult Celiac Sprue 
Diarrhea - 30 patients 
Weight Loss - 23 patients 
Weakness - 11 patients 
"cramps and gas" - 10 patients 
Abdominal pain - 9 patients 
Flatus - 8 patients 
Anorexia - 6 patients 
Abdominal distention - 5 patients 
Muscle cramps - 4 patients 
Bone pain - 4 patients 
Peripheral edema - 4 patients 
Nausea and vomiting - 3 patients 
Fatigue - 3 patients 
Purpura - 2 patients 
Sore tongue - 2 patients 
Paresthesias - 2 patients 
Rectal incontinence - 2 patients 
Increased skin pigmentation - 2 patients 
Joint pain - 1 patient 
GI bleeding - 1 patient 




Physical Signs at Initial Presentation 
of 32 Patients with Adult Celiac Sprue 
Increased skin pigmentation - 7 patients 
Rash - 7 patients 
Cachexia (or muscle wasting) - 8 patients 
Peripheral edema - 6 patients 
Clubbing - 6 patients 
Abdominal tenderness - 4 patients 
Pale conjunctiva - 3 patients 
Abdominal distention - 2 patients 
"arthritis" - 1 patient 
Lymphadenopathy - 1 patient 
Bleeding (nose) - 1 patient 
Hyperactive bowel sounds - 2 patients 
Stomatitis - 1 patient 
Palpable loops - 1 patient 
Hepatomegaly - 1 patient 
Stool Benzidine - positive - 3 patients 
negative - 18 patients 




Biochemical Abnormalities at Initial Presentation 
of 32 Patients with Adult Celiac Sprue 
Number of Number of 
Patients Patients 
Abnormal Tested Definition of Abnormal 
D-xylose 25/27 less than 4.5 grams 
Carotene 28/29 less than 70 ug% 
Fecal fat 
(24 hour) 20/21 greater than 6 grams 
Albumin 16/30 less than 3.4 gm% 
Calcium 13/28 less than 9.1 mg% 
Iron 7/18 less than 60 ug% (male) 
less than 50 ug% (female) 
Electrolytes 1/32 Na less than 34mEq/L 
HCO3 less than 25.1 mEq/L 
K+ less than 3.6 mEq/L 
Cl less than 100 mEq/L 
Hematocrit 12/32 less than 40% (male) 
less than 38% (female) 
Prothrombin time 12/27 less than 100% 




Total Length of Follow-up in 32 



























Number of Patients Followed at Various Time Intervals 
Number of Patients 
followed Clinically Number of Patients 
Time Intervals and/or Biochemically Biopsied 
Presentation 32 32 
3-6 months 21 14 
9-12 months 15 8 
2 years 7 7 
3 years 5 2 
4 years 7 4 
5 years 2 1 
6 years 2 2 




Clinical Scores of 32 Patients with Adult Celiac Sprue 
Maximum Score 
Minimum Score 
= 16 (severe 
= 4 (normal 
symptoms) 
- no symptoms) 
Presen- 
tation 3-6mo. 9-12mo. 2yrs 3yrs 4yrs 
#1 D.H. 13 10 5 4 4 
#2 M. S . 11 4 4 4 
#3 J. C. 9 
#4 E . M. 15 6 11 11 
#5 S.C. 12 11 
#6 D, M. 14 4 4 
#7 N.H. 7 5 5 6 
#8 R.L. 8 4 5 
#9 R. J. 16 11 14 
#10 A. V. 12 4 5 
#11 L.W. 12 4 4 
#12 E.P. 12 5 5 
#13 E. I . 6 4 
#14 A. R. 8 4 
#15 M.C. 14 4 5 
#16 H.L . 6 5 
#17 J. W. 13 7 6 











tation 3-6mo. 9-12mo. 2yrs 3yrs 4vrs 5yrs 6yrs 
#19 J. S. 14 5 
#20 M. C. 10 4 
#21 J.D. 14 7 4 
#22 W.H. 11 4 4 
#23 P.C. 9 5 5 
#24 C.S. 7 4 4 
#25 J. T. 11 4 4 4 
#26 L.L. 11 4 
#27 A. H. 12 6 
#28 M. H. 12 12 
#29 B.L. 14 14 14 
#30 J.N. 12 7 5 
#31 R.W. 9 4 4 





Biochemical Scores of 32 Patients with Adult Celiac Sprue 
Maximum Score = 4 (severe) 
Minimum Score = 1 (normal) 
Presen¬ 
tation 3-6mc. 9-12mo, 2yrs 3yrs 4yrs 5yrs 6yrs 
#1 D.H. 3. 8 3.2 3.2 2.5 
#2 M.S. 3.2 2.5 1.7 
#3 J.C. 3.2 
#4 E.M. 3.5 
#5 S.C. 3 1.6 
#6 D.M. 2.6 2 1 
#7 N.H. 1.6 1 1 1.3 
#8 R. L. 2.6 1. 3 1 
#9 R. J. 3.6 3 3 
#10 A. V. 3.2 1.3 
#11 L.W. 3.7 1 1 
#12 E.P. 2.5 1 1 
#13 E.I, 2 
#14 A. R. 3 1 
#15 M.C. 3. 5 1.3 1.2 
#16 H.L. 2 2 2 1 
#17 J.W. 4 4 4 






tation 3-6mo. 9-12mo. 2yrs 3yrs 4yrs 5yrs 6yrs 
#19 J.S. 3. 3 
#20 M, C. 3 1.3 
#21 J.D. 2.7 1 1 
#22 W.H. 4 2 1 
#23 P.C. 2.5 1 1 1 
#24 C.S. 2 1 1 
#25 J.T. 3.1 1. 3 1 1 1 
#26 L.L. 3 1.2 
C
M
 A.H. 2.7 3.3 
#2 8 M. H. 3.2 3.0 3.8 
#29 B. L. 1.7 1.8 1 
#30 J.N. 3.2 1.3 
#31 R.W. 3.2 1 1 




Biopsy Scores in 32 Patients with Adult Celiac Sprue 
4 = severe 2 = mild 
3 = moderate 1 = normal 
X = could not find 
Presen¬ 
tation 3-6mo« 9-12mo. 2yrs 3yrs 4yrs 5yrs 6yrs 
11 D.H. 
A 
H: 3 4 
#2 M.S. X 
#3 s. c. 4 
#4 E.M. X 
#5 S .C. A ht 2 
#6 D, M. 4 
#7 N.H, X 4,4 3 
# 8 R.L. X 2 2 
#9 R. J. 4 X 
#10 A. V. 4 3 
#11 L.W. X X 2 
#12 E.P. 4 2 X 
#13 E.I. 4 
#14 A. R« 4 
#15 M.C. X 4 
#16 H, L . 4 











tation 3-6mo. 9-12mo. 2yrs 3yrs 4yrs 5yrs 6yrs 
#19 J.S. 4 
#20 M.C. 4 3 
#21 J.D. 4 
#22 W. H. A ~x 3,2 2 
#23 P.C. 4 3 3 
#24 C. S. 4 2 2 
#25 J.T. X 2 
#26 L . J-i. 4 3 
#27 A. H, 4 4 
#28 M.H. 4 3 4 
#29 B.L. X 2 
#30 J. N, 4 3 
#31 R.ltf. 4 X 




Response to the Gluten-Free Diet in 30* Patients 
with Adult Celiac Sprue 





good response - (score 4-7) 
moderate response - (score 8-11) 





good response - (score 1-1.9) 
moderate response - (score 2.0-2.9) 
poor response - (score 3.0 - 4.0) 
C. Biopsy 
good response - (score 2) 
moderate response - (score 3) 




As was mentioned, two of the patients were not followed 
after initial diagnosis. 

Table XV 
Biochemical and Biopsy Response in 28 Clinical Responders 




































Clinical, Biochemical and Biopsy Parameters 






Clinical Biochemical Biopsy 
3.2 3.8 4 
2.5 3.8 3 








1.7 1.6 4 
1 4 
1.2 1 3 
1.2 1.3 3 
1.2 1.3 3 





3.5 3.5 4 
1 1.3 









Presentation 3.2 4 4 
3-6 months 1.7 4 
1 year 1.5 4 4 
#22 W.H. 
Presentation 2.2 4 4 
3-6 months 1.2 2 3 
2 years 1.2 1 2 
4 years 1.2 1 3 
#23 P.C. 
Presentation 2.3 2.5 4 
2 years 1.2 1 3 
4 years 1.2 1 3 
6 years 1.2 1 3 
#27 A.H. 
Presentation 3 2.7 4 














Clinical Biochemical Biopsy 
3 3.2 4 
3 3.0 3 
2.5 3.8 4 
3.5 1.7 
3.5 1.8 
3.5 1 2 
- 50 

Legend for Graphs 
Graph #1 represents the clinical scores of the 
32 patients at the time of presentation, that is, 
the time the patient was initially diagnosed by 
biopsy, and at the various follow-up periods. 
The solid line connects the mean clinical score 
at presentation to the mean scores at the various 
follow-up periods. 
Graph #2 represents the biochemical scores of the 
32 patients at the time of initial presentation, 
and at the various follow-up periods. The solid 
line connects the mean biochemical score at presen¬ 
tation to the mean scores at the various follow-up 
periods. 
Graph #3 represents the biopsy scores of the 32 
patients at the time of initial presentation, and 
at the various follow-up periods. The solid line 
connects the mean biopsy score at presentation to 
the mean scores at the various follow-up periods. 
Graph #4 represents the mean values of the three 
parameters, clinical, biochemical and biopsy, 





















































































































































































































- Normal: villi tall, slender, and uniform 
in size and shape, villus/crypt ratio 3/1 
or greater. Epithelial cells have clear 
cytoplasm and are columnar, with nuclei 
placed regularly at the cell base. Brush 
border is uniformly thick. Round cells 
are present in the lamina propria, but are 
not concentrated there. 
- Mild changes: villi are formed, but are 
somewhat broader and shorter than normal. 
The villi and the villus/crypt ratio 
often approach normality. However, epi¬ 
thelial cells, especially at the tips of 
the villi, are still abnormal, often the 
nuclei are not basally located, and the 
cells themselves are not as tall and 
columnar as in the normal biopsy. Round 
cells are present in an increased concen¬ 
tration in the lamina propria. The brush 
border has usually returned to normal, 
except, again, at the very tips of the 
villi, 
- This group encompases the wide range 
between mild and severe. Villi are 
present, but they are broad and short. 
Epithelial cells are not yet columnar, 
and their nuclei are disoriented, but 
less so than in Figure 4. The round 
cell infiltrate is dense, but again, 
less so than in the severe biopsy. 
The villus/crypt ratio is often still 
less than 1. 
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Legend for Figures 
(continued) 
Figure 4 - Complete absence of villi, or, at best, 
very short and very broad. There is 
flattening of the mucosal surface, with 
absence and irregularity of the brush 
border. The epithelial cells themselves 
are columnar, often vacuolated, and have 
nuclei scattered anywhere from the base 
of the cell to the tip. The villus/crypt 
ratio is less than 1 and often is 1/3 or 
less. There is an obvious increase in 
mitotic figures in the crypts. There 
is a dense infiltrate in the lamina 
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